Technology IntegrationThe integration of AI-driven platforms like Egnite's CardioCare could enhance TAVR growth through improved patient referral and care management.

Bears Say

Competitive LandscapeMedtronic's Evolut shows statistically significant superiority over EW's Sapien on bioprosthetic-valve dysfunction.

Financial GuidanceHigher than expected SG&A drove a ~180bp operating margin miss, which may be viewed critically by some investors.

Product PerformanceSmart trial reported a 20% paravalvular leak rate for Sapien 3, which is higher than the 10-12% rates observed in real-world registries such as the TVT registry.

---

Financials

Annual

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

1.06% Insiders

22.27% Mutual Funds

21.41% Other Institutional Investors

55.26% Public Companies and

Individual Investors

Detailed Ownership Overview >

0REN FAQ

What was Edwards Lifesciences’s price range in the past 12 months?

Currently, no data Available

What is Edwards Lifesciences’s market cap?

Currently, no data Available

When is Edwards Lifesciences’s upcoming earnings report date?

Edwards Lifesciences’s upcoming earnings report date is Apr 25, 2024 which is in 2 days.

How were Edwards Lifesciences’s earnings last quarter?

Edwards Lifesciences released its earnings results on Feb 06, 2024. The company reported CHF0.583 earnings per share for the quarter, beating the consensus estimate of CHF0.58 by CHF0.003.

Is Edwards Lifesciences overvalued?

According to Wall Street analysts Edwards Lifesciences’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Edwards Lifesciences pay dividends?

Edwards Lifesciences does not currently pay dividends.

What is Edwards Lifesciences’s EPS estimate?

Edwards Lifesciences’s EPS estimate is CHF0.59.

How many shares outstanding does Edwards Lifesciences have?

Edwards Lifesciences has 601,300,000 shares outstanding.

What happened to Edwards Lifesciences’s price movement after its last earnings report?

Edwards Lifesciences reported an EPS of CHF0.583 in its last earnings report, beating expectations of CHF0.58. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Edwards Lifesciences?

Among the largest hedge funds holding Edwards Lifesciences’s share is Fisher Asset Management LLC. It holds Edwards Lifesciences’s shares valued at 544M.

---

Edwards Lifesciences Stock Smart Score

Outperform

Fundamentals

Return on Equity

22.52%

Trailing 12-Months

Asset Growth

12.91%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Edwards Lifesciences

Incorporated in 1958, California-based Edwards Lifesciences Corp. is a medical technology company, which specializes in structural heart disease and critical care and surgical monitoring. It reports in three segments: Transcatheter Aortic Valve Replacements, Transcatheter Mitral and Tricuspid Therapies and Surgical Structural Heart and Critical Care.

---

0REN Earnings Call

Q4 2024

0:00 / 0:00

---

0REN Net sales Breakdown

64.61% Transcatheter Aortic Valve Replacement

16.64% Surgical Structural Heart

15.46% Critical Care

3.29% Transcatheter Mitral and Tricuspid Therapies

---

0REN Stock 12 Months Forecast

Average Price Target

―

eyJuYXZpZ2F0b3IiOnsiZGlzYWJsZWQiOnRydWV9LCJleHBvcnRpbmciOnsiZW5hYmxlZCI6ZmFsc2V9LCJ0aXRsZSI6eyJ0ZXh0IjpudWxsfSwiY2hhcnQiOnsiaGVpZ2h0IjoyMDAsInN0eWxlIjp7ImZvbnRGYW1pbHkiOiJwbHVzX3RyX3NhbnMiLCJmb250V2VpZ2h0IjoiNDAwIiwiY29sb3IiOiIjNWQ1ZDVlIn19LCJ5QXhpcyI6eyJsYWJlbHMiOnsic3R5bGUiOnsiY29sb3IiOiJpbmhlcml0In19LCJ2aXNpYmxlIjpmYWxzZX0sInBsb3RPcHRpb25zIjp7InNlcmllcyI6eyJzdGF0ZXMiOnsiaW5hY3RpdmUiOnsib3BhY2l0eSI6MX19fX0sInhBeGlzIjp7ImxhYmVscyI6eyJzdHlsZSI6eyJjb2xvciI6ImluaGVyaXQifX0sInZpc2libGUiOmZhbHNlfSwibGVnZW5kIjp7InN5bWJvbFJhZGl1cyI6MCwic3ltYm9sUGFkZGluZyI6NCwic3ltYm9sSGVpZ2h0IjoxNCwiYm9yZGVyV2lkdGgiOjAsInN5bWJvbFdpZHRoIjoxNCwiYWxpZ24iOiJsZWZ0IiwidmVydGljYWxBbGlnbiI6ImJvdHRvbSIsImVuYWJsZWQiOmZhbHNlfSwidG9vbHRpcCI6eyJiYWNrZ3JvdW5kQ29sb3IiOiJ3aGl0ZSJ9LCJjcmVkaXRzIjp7ImVuYWJsZWQiOmZhbHNlfSwiYWNjZXNzaWJpbGl0eSI6eyJkZXNjcmlwdGlvbiI6IiJ9LCJzZXJpZXMiOlt7InR5cGUiOiJhcmVhIiwiZGF0YSI6W119XX0=

Detailed Analyst Forecast >

Similar Stocks

Edwards Lifesciences

―

MDT

Medtronic

―

ABT

Abbott Labs

―

IART

Integra Lifesciences